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SKIN PROTEOLYTIC ENZYMES IN NORMAL RATS AND RATS SUBMITTED
TO PASSIVE CUTANEOUS ANAPHYLAXIS*
THEODOR INDERBITZJN, M.D.
One of the earliest suggested explanations of
allergic manifestations, especially of anaphylactic
shock, is an activation of proteolytic enzymes by
the antigen-antibody interaction (1). The activa-
tion of such enzymes would represent the basic
step in a series of reactions leading up to the
clinical symptoms and to the release of bio-
chemical substances, such as histamine. There is
considerable evidence that proteolytie enzymes
are involved in systemic anaphylaxis (2); but
there is as yet no evidence that such enzymes
play part in the anaphylactie reactions of the
skin.
The present study was undertaken in order to
determine whether or not proteolytie enzymes
extractable from rat skin participate in a
passively induced cutaneous anaphylaetic re-
sponse. The isolation and the characterization of
two proteolytie enzyme systems obtained both
from normal rat skin and from rat skin sub-
mitted to a passive anaphylactic reaction will
be described. A lack of relationship of one of
these two enzyme systems to passive cutaneous
anaphylaxis will be demonstrated.
MATERIALS AND METHODS
1. Animals: White male rats (Wistar strain)
weighing about 100 g were used. The hair was
removed from the abdomen with electric clippers.
2. Induction of Passive Cutaneous Anaphylaxis:
For each experiment groups of 10 to 20 rats were
used. Skin sensitivity was induced by the intra-
dermal injection of an anti-human-albumin rab-
bit immune serum diluted with an equal amount
of 0.25 M saline solution. No determination of the
antibody nitrogen content in the immune serum
was performed. Each animal received a set of six
intradermal injections of 0.05 ml of immune serum
into the abdominal skin, in such a fashion that an
area of approximately 2 to 3 cm2 was covered at
each preparation. Four and one half hours later
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the antigen (0.5 ml of a 1% solution of crystallized
human albumin dissolved in an equal amount of
0.25 M saline) was injected into a tail vein. After
this challenge edema developed at the 6 sites of
antibody injection. The individual 6 areas of
edema merged into one large edematous region
which reached its maximum within 40 to 60
minutes after the challenge and subsided com-
pletely within 24 hours. The animals were killed
and bled by decapitation in subsequent intervals
after the challenge. The skin from the combined
site of the anaphylaetie reaction was removed and
pooled.
3. Extraction of Proteolytic Enzymes from the
Skin: The samples of skin were cut into small
pieces and immediately immersed into ice cold
acetone for dehydration. They were freed from
adherent subcutaneous tissue and dried under
vacuum at room temperature. The dried skin was
passed through a Wiley mill, yielding a fine
powder, which then was suspended in ice cold
acetone. The material was allowed to precipitate.
The acetone was then carefully decanted and the
skin powder dried under vacuum.
The two proteolytie enzymes of the skin were
extracted as follows (Table 1): A 0.0GM phosphate
buffer containing KC1 of 0.8 ionic strength was
used for extraction according the method de-
scribed by Beloff and Peters (3). 25 ml of phos-
phate-KCI-buffer solution was added for each
gram of dried skin powder. This mixture was
shaken for 40 minutes in a 38° water bath. There-
after the mixture was centrifuged at 5° at 2,000
rpm for 20 minutes. The supernatant solution was
filtered through a Whattman filter No 43 and
dialysed overnight against 0.25 M NaCI at 4°. The
dialyzed solution was designated Fraction A.
For further purification and separation of the
two proteolytie enzyme systems present in
Fraction A our recently published method (4) was
modified as follows: Fraction A was diluted with
an equal volume of 0.25 M saline solution and
adjusted to a pH of 3.5 by the addition of glacial
acetic acid. Through acidification a precipitate
was formed, which contained one of the proteo-
lytic enzyme systems. The other enzyme system
was present in the supernatant solution.
The precipitate was centrifuged for 30 minutes
at 2,000 rpm at 5° and washed once with a 0.25 M
NaCI solution adjusted to a pH of 3.5 with acetic
acid. The washed precipitate was resuspended in
0.25 M NaCI and then 0.2 N NaOH was added
slowly until the precipitate dissolved. The solu-
tion was dialyzed for 48 hours at 4° against fre-
quently exchanged distilled water, whose pH was
adjusted to 8.4 with NaOH (The alkaline pH
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TABLE 1
Extraction for Skin Proteolytic Enzymes
Acetone dried skin powder
Extract with KCI phosphate buffer
0.8 ionic strength (25 mug skin pow-
der) 40 mm. at 38°
Centrifuge at 5°, 2,000rpm, 20 minutes
Dialyze against 0.25 M NaC1 over-
night at 4°
Fraction A
add equal vol. of 0.25 M NaC1 and
acidify with glacial acetic acid to
pH 3.51
Precipitate
wash once with 0.25 M
NaC1 of pH 3.5
Disperse sediment in 0.25
M NaC1; add NaOH until
sediment has dissolved
Dialyze 48 hours against
dist. water (pH 7.4)
____________
Lyophylize
Fraction B
prevents precipitation of the dissolved material
which easily occurs under acid conditions). The
dialyzed material was then lyophylized. The
white powder thus obtained was designated Fray-.
tion B.
The supernatant solution which had a pH of
3.5 was dialyzed for 48 hours against distilled
water at 4°. In the course of dialysis a precipitate
usually formed which was free of proteolytic
activity when casein was used as substrate. It was
therefore removed by centrifugation at 4°. The
remaining supernatant was then lyophylized,
yielding a white powder which was designated
Fraction C.
4. Estimation of Proteolytic Activity: The pro-
teolytic activity of the extracts was determined
by using the casein (casein Hammarstein) diges-
tion method of Kunitz (5). Measured amounts of
Fractions B and C were dissolved in 0.25 M NaCl
solution (adjusted with either diluted NaOH or
HC1 to the desired pH of 8.4 for Fraction B and
pH of 6.0 for Fraction C) and brought to a volume
of 2 ml. This was mixed with an equal volume of a
1% casein solution of the same pH. (The casein
solution was prepared by dissolving the casein
in 0.1 M Sorensen phosphate buffer.) The enzyme-
casein mixtures were incubated in a water bath
at 38°. At zero time and at intervals of 30 and 12f
minutes 1 ml of the mixture was removed. Ta
these aliquots 3 ml of a 5% trichloroacetic acid
solution was added. The mixtures were allowed to
stand at room temperature for 20 minutes. A
precipitate formed and was separated from he
supernatant by centrifugation. The supernatant,
freed from the trichioroacetic acid precipitated
material, was used for measurements of increased
absorption at 280 rnj in a Beckman DU spectro-
photometer. The increased absorption at 280 rn
served as an index for proteolytic activity.
RESULTS
I. Proteolytic Activity of the Enzyme
Preparations Fractions A, B and C
obtained from Normal Skin
Fraction A: Fraction A, which contains two
enzyme systems, was lyophylized in order to
compare its proteolytic activity with that of the
other fractions on a dry weight basis (mg). The
proteolytic activity of Fraction A is shown in
Fig. 1.
Fraction B: The proteolytic activity of Fraction
B is also shown in Fig. 1. The lyophylized material
was dissolved in 0.25 M saline. Its activity was
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FIG. 1. Illustrates the proteolytic activity of
the enzymes contained in the Fractions A, B, and
C, obtained from normal skin. A: 10mg/mi solvent(dist. water): 2 ml + 2 ml 1% casein solution of
pH 8.4 B: 2.5 mg/ml solvents (NaC1): 2 ml + 2 ml
1% casein solution of pH 8.4 C: 5.0 mg/ml solvent(NaCI): 2 ml + 2 ml 1% casein solution of pH 6.0.
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approximately 10 times greater than that of
Fraction A as calculated on the basis of dry
weight. It has to be noted however, that Fraction
A contained salts, whereas Fraction B was free
of salts. The proteolytic activity of Fraction B
was proportional to the amount of dry weight
used. The average yield of Fraction B was 35 7
mg per gram dried skin powder.
Fraction C: The proteolytic activity of Fraction
C was 16 to 20 times less than that of Fraction B
(Fig. 1). The proteolytic enzyme activity of
Fraction C was optimal at a pH of 5.8 to 6.2. No
further studies with Fraction C have been done
so far.
II. Studies with Fraction B obtained from
Normal Skin
Influence of pH: The enzyme activity of
Fraction B was optimal at pH 7.4 to 8.4 (Fig. 2).
The pH activity curve was obtained by dis-
solving 1.25 mg of Fraction B per ml (2 ml) of
of 0.25 M saline, adjusted to the desired pH
with alkali or acid. This solution was added to 2
ml of a 1 % casein solution in Sorensen phosphate
buffer of the desired pH. The mixture was
incubated at 38° for 120 minutes and the increase
in absorption of the supernatant after trichioro-
acetic acid precipitation was determined at 280
m1. The enzyme solution was found to be clear
I.0
0.
at a slightly alkaline pH and somewhat turbid at
an acid pH.
Effect of Temperature: Pre-incubation of
Fraction B at 56° for 30 minutes destroyed
approximately 50% of the enzyme activity,
while 70° destroyed 90% of the proteolytic
activity (Fig. 3).
Inhibition of Proteolytie Activity by Serum:
Beloff (6) had observed in her experiments that
the proteinase activity of a KCI extract of acetone
dried skin of 0.8 ionic strength (identical with
our Fraction A) could be inhibited by 70—80%
by incubation at 38° for 30 minutes with rat or
human plasma prior to the assay with casein.
When Fraction B was dissolved in a 0.25 M
saline solution of pH 8.4 to which had been added
between 1 to 10% fresh rat, guinea-pig or rabbit
serum and was preincubated for 30 minutes at
38°, proteolysis by Fraction B was inhibited
proportionally to the amount of serum used
(Fig. 4).
Influence of Streptokina.se on Fraction B:
Streptokinase (Varidase Lederle), 200 to 1,000
to 5,000 units per ml was added to the solutions
of Fraction B either alone or together with fresh
guinea-pig serum (as a source of complement;
see discussion) in a concentration of 1 to 10%.
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FIG. 4. Curve 1 demonstrates the proteolytic
activity of 2.5 mg/mI solvent (NaC1) of Fraction
B at a pH of 8.4. Curve 2: the same preparation
containing 1% fresh rat serum. Curve 3: the same
preparation containing 10% fresh rat serum.
The mixtures were incubated for 10 minutes
at 38° prior to the assay. No increased proteo-
lytie activity of Fraction B was observed. In the
mixtures which contained Fraction B, strepto-
kinase and serum complement, the inhibitory
effect of seruni on the proteolytic activity of
Fraction B occurred, as described above.
Vascular Effects of Fraction B: The intradermal
injection of 0.1 ml of Fraction B, dissolved in
0.25 M saline, provoked in rats a rapid increase
in vascular permeability, leading to edema
formation, which in the range studied (0.05 to
0.5 mg of Fraction B) was proportional to the
amount of Fraction B used. The diameter of the
edematous lesions after the intradermal injection
of Fraction B was made visible by the simul-
taneous intravenous injection into a tail vein of
0.3 ml of a 5% solution of Evans Blue. The
animals were killed 40 minutes after the intra-
dermal injection. The diameter of the areas of
blueing was measured on the undersurface of the
skin. The extent of edema obtained was compared
with the vascular action of histamine-dihydro-
chloride (Fig. 5).
Pre-treatment of animals with an antihistamine
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FIG. 5. Edematous lesions provoked by the
intradermal injection of 0.125; 0.25 and 0.5 mg of
Fraction B per 0.1 ml solvent (NaCI), and of 5,
10 and 20 gamma of histamine-dihydrochloride in
the same volume of saline solution. The lesions
were measured 40 minutes after the intradermal
injection.
(50 mg of Phenergan/kg), intraperitoneally 30
to 45 minutes prior the intradermal injection of
Fraction B completely abolished the vascular
effects not only of histamine but also of Fraction
B (Fig. 6).
Fraction B did not contain histamine in
detectable amounts as shown by negative tests
when assaying it on the isolated atropinized
guinea-pig ileum.
III. Proteolytic Activity of Fraction B from
Rat Skin submitted to a Passive Cuta-
neous Anaphylactic Reaction
The anaphylactically reacting skin areas of
10 to 20 rats were pooled. Fraction B was ex-
tracted from the anaphylactically reacting skin
40 to 60 minutes, 2, 6 and 24 hours after the
challenge. No alterations in the proteolytic
activity of Fraction B obtained from anaphy-
lactically reacting skin was found on comparison
with normal skin. The average yield of Fraction
B per g. dried skin powder did not significantly
differ from that obtained from normal skin.
No differences in the vascular permeability
increasing effect was found between Fraction B
obtained from normal and obtained from ana-
phylactic challenged rat skin.
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FIG. Ii. The edematous lesions on the left side were produced by the intradcrmal injection of 0.5,
0.25 and 0.125 mg of Fraction B. To the right 0.5 and 0.25 mg were injected into an animal pretrcated
with 50 mg.kg of phenergan.
Discussion
A typical example of an experimental evanes-
cent type of a cutaneous anaphylactic response
(urticarial wheal) is the passive cutaneous
anaphylaxis in laboratory animals. It is not
abolished by antihistamine drugs (7), and occurs
in rat skin previously depleted of its histamine in
the same size and the same intensity as in nor-
mal rat skin (8). Passive cutaneous anaphylaxis
in rats furthermore releases histamine not only
at the site of the antigen-antibody interaction,
but also in the adjoining skin area where no
edema occurs (9). All these findings suggested
that histamine release, is not the immediate con-
sequence of the local antigen-antibody interac-
tion, nor the cause of the vascular disturbances
(edema) seen in this type of cutaneous anaphy-
laxis.
In earlier studies we had observed that the
intradermal injection of proteolytic enzymes pro-
voked tissue alterations comparable to those seen
in passive cutaneous anaphylaxis in rats (10).
We were especially interested in the observation
that streptokinase which indirectly activates
plasminogen to the proteolytic enzyme plasmin,
had similar effects. As in the passive cutaneous
anaphylactic reaction streptokinase released
histamine in the skin not only at the site of the
injection, but also in the adjoining control area
of skin, where no edema occurred. The edematous
reaction following intradermal injection of strep-
tokinase and the edematous reaction that follows
passive cutaneous anaphylaxis depended both
upon the availability of serum complement. In
other experiments we had observed that fresh
rat skin previously submitted to passive cutane-
ous anaphylaxis showed a decreased proteolytic
activity in vitro when compared with normal
skin (6). This in vitro decrease of proteolytic ac-
tivity after a cutaneous anaphylactic reaction
prompted us to investigate as to whether or not
proteolytic enzymes extractable from rat skin
participate in vivo in this type of a cutaneous
allergic manifestation. Fraction B, representing
one of two enzyme systems, extractable from
rat skin was studied in this respect. The pro-
teolytic enzyme system contained in this Fraction
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B was fairly heat stable. It digested casein opti-
mally at a slight alkaline pH. The proteolytic
activity of Fraction B was not influenced by
streptokinase, regardless whether complement
was present or not. Yamura and Cormia (1961)
(11) had reported that extracts of human skin
contained a proteolytic active component, whose
activity could be increased through the addition
of streptokinase. They assumed however that
this proteolytic enzyme originated from the in-
terstitial tissue fluids rather than from the skin
tissue per se. The proteolytic activity of our Frac-
tion B was strongly inhibited by fresh serum.
This inhibitory effect of serum upon skin en-
zymes of proteolytic nature was first observed
by A. Beloff (8).
Fraction B, when injected intradermally in
rats increased the vascular permeability thus
leading to edema formation. It seems that this
increase in vascular permeability is due to the
release of histamine since it can he prevented by
pretreatment of the animals with antihistamines.
No alterations in the activity of the enzyme
Fraction B was observed in preparations obtained
from anaphylactically challenged skin in com-
parison to preparations obtained from normal
skin. There was also no significant alteration in
the average yield of the enzyme preparation per
gram dried powder obtained from anaphylactic
reacting skin as compared with that obtained
from normal skin.
SUMMARY
A proteolytic enzyme system (Fraction B) was
extracted from normal rat skin submitted to
passive cutaneous anaphylaxis. The proteolytic
activity of Fraction B obtained from anaphy-
lactically reacting skin was not different from
proteolytic activity obtained from normal skin.
The proteolytic component of Fraction B was
found to hydrolyze casein optimally at a slight
alkaline pH. It was moderately heat-stable. The
protcolytic activity of Fraction B was not in-
fluenced by strcptokinase; it was however
strongly inhibited by fresh serum from rats,
guinea-pigs or rabbits.
Although Fraction B, when injected intra-
dermally mimics the vascular disturbances seen
in passive cutaneous anaphylaxis, our data ob-
tained in these studies seem to indicate that the
proteolytic enzyme system contained in Fraction
B is apparently not responsible for edema forma-
tion observed in the wake of passive cutaneous
anaphylaxis in rats.
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DISCUSSION
Da. PETER FLESdH, Philadelphia, Pa.: I won-
der if Dr. Inderbitzin used some other animals,
because the rat is not the best animal for studies
of histamine effects.
DR. ANDREW B. LORINcE, Gainesville, Florida:
I wonder if Dr. Inderbitzin would be permitted
to have the time to give the biochemical data
that characterize this enzyme?
Dn. A. J. REIdHE5, St. Louis, Mo.: We have
been working for years at the County Hospital
in St. Louis with enzymes. We have found numer-
ous enzymes in epidermis. We find the two trans-
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aminases, GOT and GPT, proteolytic type of
things. We find arginase. May I ask—Is it pos-
sible for the presenter to be a little more specific.
Da. THEODOR M. INDERBITzIN, (in closing):
In answer to Dr. Flesch's question, we have not
been able to obtain a good active enzyme prepara-
tion from guinea-pig skin using the same method
as for rat skin.
In regard to the characterization of the en
zyme, I can say that our enzyme preparation
contains proteolytic activity on the basis of chem-.
ical and kinetic analysis of the reaction. The
enzyme preparation may contain other enzymes,
such as transaminases, in addition to proteolytic
enzymes, but we are only interested in the pro-
teolytic activity of these preparations.
